Detalhe da pesquisa
1.
Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12-month, prospective observational study.
Diabetes Obes Metab
; 2024 Apr 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38637981
2.
Improved patient-reported outcomes with iGlarLixi versus premix BIAsp 30 in people with type 2 diabetes in the SoliMix trial.
Diabetes Obes Metab
; 24(12): 2364-2372, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36053820
3.
Hypoglycaemia events with iGlarLixi versus premix biphasic insulin aspart 30 (BIAsp 30) in people with type 2 diabetes advancing from basal insulin: An analysis of the SoliMix trial.
Diabetes Obes Metab
; 24(12): 2391-2399, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36054624
4.
Efficacy and safety of iGlarLixi versus IDegAsp: Results of a systematic literature review and indirect treatment comparison.
Diabetes Obes Metab
; 23(12): 2660-2669, 2021 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-34402153
5.
Advancing therapy with iGlarLixi versus premix BIAsp 30 in basal insulin-treated type 2 diabetes: Design and baseline characteristics of the SoliMix randomized controlled trial.
Diabetes Obes Metab
; 23(6): 1221-1231, 2021 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-33606908
6.
Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial.
Diabetes Care
; 2021 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34183429
7.
Hernia de Spiegel: a propósito de un caso / Spiegel Hernia. About a case
Prensa méd. argent
; 108(6): 293-295, 20220000. fig
Artigo
em Espanhol
| LILACS, BINACIS | ID: biblio-1397092
8.
[Neonatal lupus erythematosus: Suspect and diagnosis]. / Lupus eritematoso neonatal: sospecharlo, para diagnosticarlo.
An Pediatr (Engl Ed)
; 95(5): 387-388, 2021 11.
Artigo
em Espanhol
| MEDLINE | ID: mdl-33478848